Profile data is unavailable for this security.
About the company
Apontis Pharma AG is a Germany-based manufacturer of pharmaceutical preparation. The company focuses on the commercialization of pharmaceutical products to General Practitioners and engages in the marketing and sale of medical drugs for indication fields of internal medicine in Germany.
- Revenue in EUR (TTM)36.96m
- Net income in EUR-9.40m
- Incorporated2021
- Employees177.00
- LocationApontis Pharma AGAlfred-Nobel-Strasse 10Monheim Am Rhein 40789GermanyDEU
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biofrontera AG | 32.25m | -369.00k | 21.33m | 88.00 | -- | 0.9189 | 50.54 | 0.6614 | -0.0654 | -0.0654 | 6.16 | 3.82 | 1.02 | 1.27 | 42.49 | 366,465.90 | -1.16 | -11.99 | -1.64 | -15.19 | 80.64 | 84.28 | -1.14 | -20.93 | 1.26 | 0.7071 | 0.0525 | -- | 25.30 | 8.85 | 99.16 | -- | 12.20 | -- |
| NanoRepro AG | 13.93m | -6.58m | 22.07m | 17.00 | -- | 0.5146 | -- | 1.58 | -0.5328 | -0.5328 | 1.14 | 3.32 | 0.2864 | 1.44 | 1.53 | 733,372.60 | -13.52 | 20.52 | -13.92 | 23.15 | 32.46 | 35.59 | -47.22 | 11.83 | 42.54 | -- | 0.00 | 31.99 | -76.35 | 87.53 | -112.53 | -- | 56.67 | -- |
| B.M.P. Pharma Trading AG | 1.64k | 1.57m | 32.80m | 45.00 | 20.90 | -- | 20.89 | 19,998.28 | 0.299 | 0.299 | 0.0003 | -- | -- | -- | -- | 36.44 | -- | 16.68 | -- | 17.58 | -46.34 | 0.2347 | 95,712.20 | 87,097.18 | -- | -493.86 | -- | -- | -96.34 | -61.60 | 75.39 | 43.01 | -- | -- |
| MediGene AG | -100.00bn | -100.00bn | 41.41m | 86.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -22.31 | -- | -25.28 | -- | 90.15 | -- | -123.17 | -- | -- | -- | -- | -80.69 | -4.89 | -94.20 | -- | -8.12 | -- |
| BRAIN Biotech AG | 55.23m | -8.40m | 60.08m | 311.00 | -- | 2.93 | -- | 1.09 | -0.3843 | -0.3843 | 2.53 | 0.9375 | 0.7778 | -- | -- | 167,351.50 | -11.67 | -10.71 | -15.18 | -14.46 | 56.12 | 56.16 | -15.01 | -17.47 | -- | -2.80 | 0.00 | -- | 11.79 | 14.12 | -25.63 | -- | 14.47 | -- |
| Apontis Pharma AG | 36.96m | -9.40m | 76.84m | 177.00 | -- | 2.45 | -- | 2.08 | -1.10 | -1.10 | 4.37 | 3.69 | 0.682 | 3.01 | 15.40 | 208,835.00 | -15.87 | -- | -18.25 | -- | 63.77 | -- | -23.27 | -- | 2.63 | -- | 0.1658 | -- | -33.67 | -- | -520.38 | -- | -- | -- |
| 4Sc AG | 304.00k | -8.24m | 77.84m | 15.00 | -- | 15.90 | -- | 256.06 | -0.8144 | -0.8144 | 0.0301 | 0.4995 | 0.0236 | -- | 3.68 | 20,266.67 | -63.84 | -39.49 | -77.78 | -42.84 | 68.75 | 92.24 | -2,709.54 | -337.74 | -- | -- | 0.00 | -- | -30.28 | -40.78 | 42.64 | -- | -56.05 | -- |
| Cantourage Group SE | -100.00bn | -100.00bn | 86.09m | 2.00 | -- | 1.95 | -- | -- | -- | -- | -- | 3.72 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- |
| Haemato AG | 260.81m | 9.61m | 90.42m | 78.00 | 9.23 | 0.5929 | 8.40 | 0.3467 | 1.84 | 1.84 | 50.10 | 28.67 | 1.47 | 9.80 | 12.48 | 3,343,690.00 | 5.41 | 2.01 | 6.45 | 2.70 | 7.56 | 8.42 | 3.68 | 1.21 | 1.66 | -- | 0.0203 | 157.20 | -12.95 | -3.03 | 25.39 | 3.32 | -5.75 | -16.74 |
| Heidelberg Pharma AG | 9.05m | -18.28m | 138.42m | 98.00 | -- | 3.07 | -- | 15.29 | -0.3957 | -0.3957 | 0.196 | 0.968 | 0.1222 | 0.2187 | 11.87 | 95,273.69 | -24.68 | -43.91 | -33.18 | -64.34 | 79.75 | 52.13 | -201.94 | -206.24 | 2.22 | -- | 0.104 | -- | -46.75 | 21.87 | -3.27 | -- | -0.8341 | -- |
| PharmaSGP Holding SE | 101.10m | 16.40m | 273.60m | 89.00 | 16.68 | 6.88 | 10.62 | 2.71 | 1.37 | 1.37 | 8.43 | 3.32 | 0.7765 | 1.11 | 11.41 | 1,135,944.00 | 12.59 | 13.70 | 15.39 | 19.98 | 90.64 | 90.20 | 16.22 | 17.56 | 2.14 | 8.97 | 0.6505 | -- | 17.80 | 10.78 | 37.17 | 2.16 | 25.88 | -- |
Data as of May 17 2024. Currency figures normalised to Apontis Pharma AG's reporting currency: Euro EUR
19.24%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Kreissparkasse Biberachas of 31 Jan 2024 | 565.00k | 6.65% |
| Deka Investment GmbHas of 30 Nov 2023 | 248.77k | 2.93% |
| UBS Asset Management (UK) Ltd.as of 31 Oct 2023 | 238.46k | 2.81% |
| Ehrke & L�bberstedt AGas of 29 Feb 2024 | 152.80k | 1.80% |
| LOYS AGas of 30 Jun 2023 | 123.24k | 1.45% |
| Oddo BHF Asset Management SASas of 31 Mar 2023 | 91.73k | 1.08% |
| GVC Gaesco Gesti�n SGIIC SAas of 31 Mar 2024 | 72.00k | 0.85% |
| Do Investment AGas of 30 Jun 2023 | 52.12k | 0.61% |
| UBS LA MAISON de Gestionas of 30 Apr 2024 | 51.10k | 0.60% |
| Aktia Varainhoito Oyas of 30 Apr 2024 | 40.00k | 0.47% |
More ▼
Data from 30 Jun 2023 - 30 Apr 2024Source: FactSet Research Systems Inc.
